ArticleWorld journal of microbiology & biotechnology2026
Bioproducts from marine macroalgae Caulerpa taxifolia: production of biodiesel, biochar and biopolysaccharide using biorefinery approach.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Seaweeds have been consumed as food traditionally, which has garnered renewed interest from researchers and industry as a prolific source of bioactive metabolites with biological significance. This study aimed to extract bioproducts from the invasive Caulerpa taxifolia including lipids and biochar for biodiesel production and polysaccharides for wound-healing applications. For this, three different methods like mechanical, water bath and ultrasound assisted extractions were performed with seven seaweeds including Halimeda gracilis, Turbinaria conoides, Sargassum polycystum, Caulerpa taxifolia, Padina boergesenii, Spatoglossum asperum and Gracilaria crassa. Among them, higher lipid content (5.7 ± 0.04%) was scored with Caulerpa taxifolia by water bath-assisted extraction. The leftover seaweed biomass was further subjected to recovery of polysaccharides through ultrasound, microwave and ultrasound-microwave-assisted extractions, in which the ultrasound-assisted extraction yielded a maximum of 4.1 ± 0.05%. Structural confirmation of the extracted crude polysaccharide was evaluated by FT-IR, XRD and TGA. Then, the synthesized and seaweed-derived activated biochar catalyst (SDABC) was employed for the transesterification that enhanced the FAME recovery up to 96% of SFA and MUFA than homogenous catalysts. The structural moieties of seaweed derived biochar catalyst (SDBC) and SDABC were characterized by FT-IR, BET, SEM, and EDX analysis. Furthermore, the extracted crude polysaccharides (50, 100 and 150 µg/mg) were examined for wound-healing in C. elegans and the worms healed within 24 h at 150 µg/mg, which showed the polysaccharide efficacy against therapeutic potential. In conclusion, this study demonstrates the utilization of the entire seaweed biomass of underexploited C. taxifolia to produce various bioproducts through zero-waste concept.
Indexed as
Identifiers
41718968What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.